Tag Archives: lasting

Salman Khan touches Usha Uthup’s feet at Umang 2023, leaves a lasting impression on his fans – timesofindia.com

  1. Salman Khan touches Usha Uthup’s feet at Umang 2023, leaves a lasting impression on his fans timesofindia.com
  2. Deepika Padukone In A Sabyasachi Saree Was Just A Royal Display Of Ethnic Style At Umang 2023 NDTV
  3. Ranbir Kapoor’s stellar moves light up recent event as he dances to ‘ Pyaar Hota Kayi Baar Hai’ timesofindia.com
  4. Deepika Padukone, Kiara Advani, Janhvi Kapoor, Ananya Panday and others: Divas who ditched gowns for sarees at Umang Hindustan Times
  5. Umang 2023: From Arbaaz Khan confirming his second wedding to Shah Rukh Khan and Salman Khan’s energetic performances, a peek inside the star-studded event The Indian Express

Read original article here

Study finds more than 1 in 3 women have lasting health problems after giving birth – Yahoo Life

  1. Study finds more than 1 in 3 women have lasting health problems after giving birth Yahoo Life
  2. ‘Completely ignored’: Why health problems caused by childbirth are neglected CNN
  3. Are low sex drive, anxiety, back pain and depression linked to post-childbirth care? What does Lancet report author have to say? The Indian Express
  4. 40M women will likely experience problems after childbirth each year, study finds Global News
  5. A third of women suffer long-term medical consequences after giving birth. These 9 ‘underreported’ health problems are impacting millions Yahoo Finance

Read original article here

Shakira leaves Gerard Piqué’s native Spain and moves family to Miami: ‘Friendship is more lasting than love’ – Fox News

  1. Shakira leaves Gerard Piqué’s native Spain and moves family to Miami: ‘Friendship is more lasting than love’ Fox News
  2. Piqué gave full custody of kids to Shakira before her move to Miami: Report HOLA! USA
  3. Shakira Announces She’s Leaving Barcelona Following Gerard Pique Split | E! News E! News
  4. From Scathing Lyrics to Casio Watches: A Timeline of Shakira and Gerard Piqué’s Separation Rolling Stone
  5. Shakira starts new life with her children in Miami: These are the luxuries found in her new mansion Marca English
  6. View Full Coverage on Google News

Read original article here

Could taking a depression pill prevent lasting agony of shingles?

Sitting in A&E, with piercing pain radiating across his forehead and his left eye, David Hadfield clutched his head, struggling to work out what was going wrong.

The answer emerged during his hour-long wait at Manchester Eye Hospital. A ‘bumpy, burning rash’ began to develop down one side of his forehead, just above his left eye and eyebrow, a symptom which immediately ‘gave the game away’ to doctors examining him: he had shingles.

‘I was absolutely astounded,’ says David, 76, who lives in Alderley Edge in Cheshire. ‘I didn’t know much about the condition, but I certainly didn’t think it could affect your face or eyes. It came out of nowhere.’

Four months on — six weeks of which was spent in a darkened room to prevent light aggravating his sensitive eye — David was still in agony and relying on large doses of powerful painkillers.

Professor Pickering and other researchers are launching a major trial — the Athena Shingles Study — treating newly diagnosed cases with amitriptyline (a type of antidepressant) 

‘You’d think that when the rash goes, which it did after about ten days, the pain would go away, too,’ says David.

‘But it has just carried on and on. There were days when I thought my eye socket was on fire because the pain was so bad. You start to think: will it ever go away?’

Shingles is a common infection caused by the reactivation of varicella zoster, the virus that triggers chickenpox. It can lie dormant in the body for years, but if your immune system is compromised the virus can escape, travelling along nerves to the skin, producing the signature blister-like rash.

While the visible signs of the virus tend to clear within a week or so, around 14 per cent of patients are left with severe nerve pain, known as post-herpetic neuralgia, which can last for up to a year and may even become permanent.

‘The problem is that there aren’t any good treatments for shingles pain,’ explains Tony Pickering, a professor of neuroscience and anaesthesia at Bristol University.

‘And, unfortunately, I have seen patients who even 20 years down the line are still suffering with some kind of pain.’

It’s why Professor Pickering and other researchers at Bristol, Oxford, Southampton and Warwick universities, are launching a major trial — the Athena Shingles Study — treating newly diagnosed cases with amitriptyline (a type of antidepressant that at lower doses is used to treat nerve pain) to try to prevent post-herpetic neuralgia.

A small study in 1997 suggested taking amitriptyline early may help, but the researchers say this new study will be the largest on the subject.

For 80 per cent of those who catch chickenpox, the virus resides in the body without causing problems, explains Dr Ashish Gulve, a consultant in pain medicine at The James Cook University Hospital in Middlesbrough and medical advisor to the Shingles Support Society.

‘However, in some people, perhaps decades later, the virus is reactivated, possibly because of advancing age — shingles is most common in the over-70s — or due to a compromised immune system which makes it harder to fight infection.’

Diseases and treatments that weaken the immune system, such as type 2 diabetes and chemotherapy, can also allow the virus to become active.

(Being exposed to chickenpox again shouldn’t be a risk. In fact, research published in the BMJ in 2020 found that adults exposed to a child with chickenpox are around 30 per cent less likely to develop shingles for up to 20 years, possibly because re-exposure to the virus boosts immunity to shingles.)

A small study in 1997 suggested taking amitriptyline early may help, but the researchers say this new study will be the largest on the subject

Shingles can appear in any nerve in the body and, once the virus is reactivated, the affected nerve starts sending pain signals even if there is no rash.

‘The hypersensitivity can be so acute that some patients can’t even touch the affected area,’ says Dr Gulve. ‘Even a cold breeze can set off pain.’

David’s problem began when he woke one morning with a headache unlike any he’d had before. Two days of taking ibuprofen had no effect and he soon felt an agonising, burning pain around his left eye.

After his diagnosis, David, a former business executive, was prescribed gabapentin, which is a medication used to treat nerve pain, as well as antivirals.

David’s vision was unaffected, but the pain in his eye, forehead and eye socket was ‘terrible’.

‘I’m a very busy and sociable person, but overnight I became someone who had to sit at home with the curtains closed all day, covering my bad eye with my hand as a way of trying to head off this awful pain,’ he says.

‘It literally felt like my eye and my forehead were burning. It also felt like something was sticking in my eye, which had become bulbous and swollen.’

At one point, David was taking 18 tablets a day.

Professor Pickering says ‘throwing the kitchen sink’ at post-herpetic neuralgia may not help and the drugs themselves have potential side-effects.

‘That is why we are interested in prevention with amitriptyline,’ he adds.

Dr Gulve says the lack of effective treatments for the long-term pain means it’s important that patients seek help quickly if they suspect it might be shingles as antivirals can stop the virus replicating.

The virus damages nerves, and the longer it’s around then the more damage it can do, says Professor Pickering.

‘The pain is the result of this damage to nerve cells. Therefore, if antivirals reduce the replication of the virus and speed its elimination, they should hasten the end of the shingles and reduce the risk of long-term pain.

‘However, this has not been convincingly demonstrated in studies, possibly because of the damage already done by the virus before people go to their GP — so we would encourage patients to go to their GP as early as possible.’

One study, updated in the Journal of Medical Virology in 2021, found that only 54 per cent of patients received antiviral treatment within 72 hours. Antivirals need to be given in the first few days of infection.

‘A key issue is lack of recognition,’ says Matthew Ridd, a professor of primary healthcare at Bristol University and one of the leaders of the Athena study.

‘Patients may not realise they have a problem that needs to be seen quickly, or that the rash is connected to also feeling under the weather, or other symptoms such as a headache,’ he says. That creates a delay in diagnosis and treatment.

Shingles presents as a rash on one side of the body, and pain in the area may precede the rash — which won’t cross the midline,’ he says (in layman’s terms, the nerves run down the body, rather than across). ‘There might also be general malaise.’

As well as long-term pain, shingles can also lead to a raised risk of cardiovascular problems. The theory is the virus causes vascular changes which lead to blockages in the blood vessels.

A study published by Brigham and Women’s Hospital in the U.S. in November found shingles was linked to an almost 30 per cent increased risk of heart attacks or strokes in those without previous cardiovascular problems.

There is no cure for shingles, but a vaccine, Zostavax, is available on the NHS to anyone in their 70s. But uptake rates in England dropped from 61.8 per cent of 70-year-olds in 2013/14 to 26.5 per cent in 2019/20, largely because of a lack of access to GPs during the pandemic.

‘If your GP hasn’t invited you to have it, ask for it,’ advises Marian Nicholson, director of the Herpes Viruses Association and Shingles Support Society.

Today, David is ‘slowly getting back to normal’.

But he adds: ‘I still have a burning sensation around my forehead and a feeling that something is sticking in my left eye. I wouldn’t wish what I’ve been through on anyone.’

The Athena trial is recruiting recently diagnosed patients: athena-study.bristol.ac.uk.

 Dr Megan Rossi is away

Adventurer and TV presenter Bear Grylls, 48, answers our health quiz

Under the microscope 

Adventurer and TV presenter Bear Grylls, 48, answers our health quiz 

Interview by Louise Flind

Can you run up the stairs?

I can and I do! Training is a habit built over many years and takes the form of a body weight routine (25 pull-ups, 50 press-ups, 75 squats and 100 sit-ups) then a weights session every other day. On alternate days, I swim or play touch tennis and I do yoga weekly.

Get your five a day?

I do in terms of fruit but not veg. I’m sceptical about the benefits, to be honest. My diet was vegan/plant-based for years, until I got Covid pretty bad. I doubled down on loads of veg and celery and all that stuff in smoothies but my kidneys got really painful. Then my eldest son [now 19], who’d been struggling with his energy, skin and stomach, got help and was weaned back to great health by eating red meat, butter, eggs, fruit and honey, and cutting out bread, pasta and veg. I couldn’t believe the transformation, but the same happened to me and I’ve now embraced an ancestral/carnivore approach — predominantly grass-fed red meat and liver, rice, eggs and dairy, with fruit and honey to finish.

My diet was vegan/plant-based for years, until I got Covid pretty bad 

Ever dieted?

Yes, but I’d be lean yet lose strength and was always hungry. Now I feel full every day, yet am fitter and leaner than ever [at 6ft, he weighs 12st 4lb].

Any vices?

Pina coladas and Dairy Milk chocolate (a square or two after meals). If I want the odd treat, that’s fine: you’ve got to live a little!

Family ailments?

My father died a few days after having a pacemaker fitted. He was 66. It was the worst moment of my life. The truth is he probably wasn’t active enough and thought eating margarine and no red meat was healthy, when actually he needed natural foods.

Worst illness/injury?

When I was 22, I broke my back when my parachute failed to open. I was lucky not to be paralysed, and spent a long time in military rehabilitation [he was in the 21 (Reserve) SAS]. It made me realise life is so precious, and I vowed to live with total commitment, energy and gratitude.

If I want the odd treat, that’s fine: you’ve got to live a little! 

Pop any pills?

I take Ancestral Supplements [his own range] which include a lot of the organs that are harder to eat in natural form, such as heart, lung, blood and bone marrow. They’re like nature’s best multivitamin.

Ever been depressed?

When Shara and I married [2000], we lost our fathers within a few months. I felt low but simple things helped: sunlight, cold water, good friends, sharing the struggles, being outside, training hard and setting goals.

What keeps you awake?

I worry about my 82-year-old mum because I know movement is so key to longevity but she is less mobile now.

Any phobias?

To this day, I feel the fear before I skydive. But never run from fears or they grow.

ancestralsupplements.com

Read original article here

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults

Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

Both companies’ vaccines produced antibodies 14 days after the first of two shots and were detectable at varying levels in both children and adults for one year, data from the studies conducted in Western Africa showed.

The vaccines are designed to target the Zaire strain of the virus, not the Sudan strain of Ebola that recently caused an outbreak and at least 56 deaths in Uganda.

The company logo for Johnson & Johnson is displayed to celebrate the 75th anniversary of the company’s listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid (Reuters Photos)

One regimen tested a dose of J&J’s vaccine, followed by a booster shot of a vaccine from Danish drugmaker Bavarian Nordic, while another tested two doses of Merck’s vaccine with eight weeks in between. A third option followed the first Merck dose with a placebo.

MODERNA AND MERCK TEAM-UP TO FIGHT MELANOMA

Ticker Security Last Change Change %
JNJ JOHNSON & JOHNSON 179.79 +0.35 +0.20%
MRK MERCK & CO. INC. 111.55 +1.37 +1.24%

“I think the study shows that both the vaccines elicit good antibody responses,” said Dr. H. Clifford Lane, one of the researchers and a clinical director at the U.S. National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH).

Only Merck’s shot can potentially be given as a single dose while J&J’s vaccine may need to continue as a two-dose regimen, Lane added.

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022, after the drugmakers said a potential skin cancer vaccine they are developing using the same te (AP Photo/Seth Wenig, File / AP Newsroom)

The NIH researchers noted that they were unable to assess the actual level of protection against the disease from the vaccines as no participants contracted Ebola during the trial, which began enrollment in 2017. But they said the vaccines were found to be safe for children and adults.

GSK VACCINE FOR OLDER ADULTS GRANTED FDA PRIORITY REVIEW

“Long-term follow up of the participants in this trial is taking place to determine if and when booster doses might be needed,” said Brian Greenwood, a study co-author from the London School of Hygiene & Tropical Medicine.

A total of 1,400 adults and 1,401 children aged 1 to 17 years old participated in the trials conducted in collaboration with Liberia Ministry of Health and with the University Clinical Research Center and the Center for Vaccine Development-Mali.

The results were published in The New England Journal of Medicine.

CLICK HERE TO GET THE FOX BUSINESS APP

Merck’s vaccine Ervebo was approved by the European regulator and prequalified by the World Health Organization in 2019. J&J’s Zabdeno got European and WHO clearances in 2020 and 2021, respectively. Bavarian Nordic’s Mvabea, used in the J&J regimen, also received European approval in 2020 and WHO prequalification in 2021.

Ticker Security Last Change Change %
BVNRY BAVARIAN NORDIC 10.43 +0.00 +0.00%

Read original article here

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults

Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

Both companies’ vaccines produced antibodies 14 days after the first of two shots and were detectable at varying levels in both children and adults for one year, data from the studies conducted in Western Africa showed.

The vaccines are designed to target the Zaire strain of the virus, not the Sudan strain of Ebola that recently caused an outbreak and at least 56 deaths in Uganda.

The company logo for Johnson & Johnson is displayed to celebrate the 75th anniversary of the company’s listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid (Reuters Photos)

One regimen tested a dose of J&J’s vaccine, followed by a booster shot of a vaccine from Danish drugmaker Bavarian Nordic, while another tested two doses of Merck’s vaccine with eight weeks in between. A third option followed the first Merck dose with a placebo.

MODERNA AND MERCK TEAM-UP TO FIGHT MELANOMA

Ticker Security Last Change Change %
JNJ JOHNSON & JOHNSON 179.79 +0.35 +0.20%
MRK MERCK & CO. INC. 111.55 +1.37 +1.24%

“I think the study shows that both the vaccines elicit good antibody responses,” said Dr. H. Clifford Lane, one of the researchers and a clinical director at the U.S. National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH).

Only Merck’s shot can potentially be given as a single dose while J&J’s vaccine may need to continue as a two-dose regimen, Lane added.

FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Shares of Merck and Moderna jumped early Tuesday, Dec. 13, 2022, after the drugmakers said a potential skin cancer vaccine they are developing using the same te (AP Photo/Seth Wenig, File / AP Newsroom)

The NIH researchers noted that they were unable to assess the actual level of protection against the disease from the vaccines as no participants contracted Ebola during the trial, which began enrollment in 2017. But they said the vaccines were found to be safe for children and adults.

GSK VACCINE FOR OLDER ADULTS GRANTED FDA PRIORITY REVIEW

“Long-term follow up of the participants in this trial is taking place to determine if and when booster doses might be needed,” said Brian Greenwood, a study co-author from the London School of Hygiene & Tropical Medicine.

A total of 1,400 adults and 1,401 children aged 1 to 17 years old participated in the trials conducted in collaboration with Liberia Ministry of Health and with the University Clinical Research Center and the Center for Vaccine Development-Mali.

The results were published in The New England Journal of Medicine.

CLICK HERE TO GET THE FOX BUSINESS APP

Merck’s vaccine Ervebo was approved by the European regulator and prequalified by the World Health Organization in 2019. J&J’s Zabdeno got European and WHO clearances in 2020 and 2021, respectively. Bavarian Nordic’s Mvabea, used in the J&J regimen, also received European approval in 2020 and WHO prequalification in 2021.

Ticker Security Last Change Change %
BVNRY BAVARIAN NORDIC 10.43 +0.00 +0.00%

Read original article here

Test shows Samsung Galaxy Z Flip 4, Z Fold 4 lasting longer than Galaxy S22 Ultra

One of the biggest complaints about Samsung’s foldable smartphones has been their battery life and charging speeds. Samsung has addressed those issues with the Galaxy Z Flip 4 and the Galaxy Z Fold 4. The Galaxy Z Flip 4 comes with a bigger battery (3,700mAh) and faster charging (25W), while both devices benefit from the more power-efficient Snapdragon 8+ Gen 1 processor.

A new video from YouTuber TechDroider shows putting the Galaxy Z Flip 4 and the Galaxy Z Fold 4 (4,400mAh) through a battery life test. These phones are pitted against Samsung’s own Galaxy S22 Ultra (5,000mAh), the Apple iPhone 13 Pro Max (4,352mAh), the OnePlus 10 Pro (5,000mAh), and the Xiaomi 12S Ultra (4,860mAh). Surprisingly, the Galaxy Z Flip 4 and the Galaxy Z Fold 4 outdo the Galaxy S22 Ultra despite a lower battery capacity.

Galaxy Z Flip 4, Galaxy Z Fold 4 battery life results

In a test that takes the phones through gaming, web browsing, and social media apps, the Galaxy S22 Ultra was the first phone to die. It lasted 8 hours and 56 minutes on a single charge, and its temperature was around 50.4°C. The Galaxy Z Flip 4 lasted 9 hours and 4 minutes, and its temperature was 42°C. The Galaxy Z Fold 4 managed to last 9 hours and 18 minutes on a single charge. Its temperature was around 39.7°C.

Both new foldable phones managed to last longer and run cooler than the Galaxy S22 Ultra. This shows how power-efficient the new Snapdragon 8+ Gen 1 chipset is compared to the Snapdragon 8 Gen 1. TSMC’s 4nm process seems much better than Samsung Foundry’s 4nm process.

The OnePlus 10 Pro lasted just one minute longer than the Galaxy Z Fold 4 but ran hotter (45°C). The Xiaomi 12S Ultra, which uses the Snapdragon 8+ Gen 1 processor, lasted 9 hours and 38 minutes on a single charge but was almost as hot (44.1°C) as the OnePlus 10 Pro. The iPhone 13 Pro Max had the best battery life with a runtime of 10 hours and 35 minutes but ran slightly hotter (40.5°C) than the Galaxy Z Fold 4.

SamsungGalaxy Z Flip 4

SamsungGalaxy Z Fold 4

Read original article here

Punishing Disney, DeSantis Signals a Lasting G.O.P. Brawl With Business

Gov. Ron DeSantis of Florida on Friday revoked Disney’s special tax privileges in the state, culminating an extraordinary clash between one of the Republican Party’s leading figures and a powerful company with deep historical ties in his state.

The move, which reverses 55 years of precedent, came after a weekslong battle with Disney that largely centered on the company’s criticism of an education law Mr. DeSantis signed that is at the center of America’s latest culture fight. The education law, called the “Parental Rights in Education” measure — or, to its critics, “Don’t Say Gay” — limits classroom instruction about sexual orientation and gender identity in some grades.

“I’m just not comfortable having that type of agenda get special treatment in my state,” Mr. DeSantis said on Friday.

Widely seen as retaliation, Mr. DeSantis’s move vividly illustrated just how drastically the G.O.P. has transformed from the days when its leaders mostly moved in lock step with the nation’s largest businesses.

But over roughly the last decade, and especially following former President Donald J. Trump’s ascent, Republicans have increasingly seen political benefit in criticizing corporate America, even as big corporations have felt rising pressure to take a stand on heated political issues.

“Republicans who for a long time have had a close and warm relationship with U.S. corporations have started to be more selective about those relationships, and aren’t afraid to confront even some popular brands that before would have been unthinkable,” said former Representative Carlos Curbelo, a Florida Republican. “Whereas before it would have been unimaginable that a politician, especially a Florida politician, would confront Mickey Mouse, now there’s actually significant political incentive to do so.”

This article will be updated.

Read original article here

UK patient dies after COVID-19 infection lasting 505 days

A British patient has died after the longest COVID infection on record — regularly testing positive for a staggering 505 days.

The unidentified patient, who had a weakened immune system, succumbed after suffering “one continuous infection” that lasted nearly 17 months, according to Dr. Luke Blagdon Snell, of Guy’s and St Thomas’ NHS Foundation Trust.

COVID throat-swab tests “were positive each time — the patient never had a negative test,” Snell told the BBC, as per The Times of London.

“And we can tell it was one continuous infection because the genetic signature of it, the information we got from sequencing the viral genome, was unique and constant in that patient,” the doctor said.

Snell told the BBC that “at 505 days, it certainly seems to be the longest reported infection.”

However, he conceded that “there’s no way to know for sure” because
“not everyone gets tested, especially on a regular basis like this case.”

Nine patients in the study had weakened immune systems, contributing to their struggle with the infection.
EPA/ Andy Rain
Protesters who lost a loved one from COVID-19, participate in a march from the National Covid Memorial wall to Downing Street in London, ,Mar. 29, 2022.
AP/Alastair Grant
NHS ambulance staff assist a patient outside the Royal London hospital in London, Britain, 12 Apr. 2022.
EPA/ Andy Rain

The now-deceased patient was one of two people in a London study that had infections lasting more than a year, the UK Times said.

Another has tested positive for 412 days — with the researchers saying it is likely they will break the 505-day record if they survive, the report said.

The nine in the study all had weakened immune systems from organ transplantation, HIV, cancer or medical therapies. Their infections averaged 72 days, the report said, with four not surviving.

Read original article here

There’s an Activity That Improves Mood With Lasting Effect in People With Depression

There’s no longer any doubt that exercise can be a serious mood booster for people with major depressive disorder. Even an hour of physical activity a week can be enough to reduce the risk of future episodes.

 

Surprisingly, little is known about the more immediate effects of exercise on specific characteristics of both mood and mind among people with depression, both during an exercise session and straight after.

“A lot of previous research on the effects of exercise on mental health, in general, have used very broad measures of wellbeing,” says Iowa State University kinesiologist Jacob Meyer.

“What we were interested in, specifically, is: how does acute exercise – that is, one session of exercise in a day – influence the primary symptoms of depression.”

Chronic forms of depression consist of a variety of mental changes that make it more than just a feeling of glumness. For many, there’s the sheer loss of enjoyment and pleasure that comes with depressive episodes – a symptom referred to as anhedonia.

Then there’s the disorder’s relationship with impaired cognitive functions, including memory loss and processing speed, which may also benefit from exercise.

To add detail to our knowledge of how a workout influences changes in both mood and mental skills, Meyer and colleagues analyzed various test scores of 30 volunteers before, during, and after either a moderately intense half-hour cycling session, or a session of quiet rest.

 

Tests included a questionnaire to evaluate current mood and feelings, a scale to measure anhedonia, and several cognitive assessments, including something called a Stroop color and word test.

Taken together, the evaluations were intended to form a clearer profile of how a person’s mental state evolves throughout an exercise session while they’re dealing with depression.

Mid-cycle, participants generally experienced an improvement in their mood, one that persisted for at least 75 minutes after the workout had ended.

Feelings of anhedonia had also lifted, though were starting to creep back 75 minutes post-workout. However, compared with those who’d quietly rested, it was still a positive result.

Perhaps more surprising were the variations in cognitive ability. In contrast with previous findings on healthy individuals, which predicted overall improved reaction times, the results among this sample were mixed.

During exercise, participants’ Stroop test results were slightly faster. Yet this dropped 25 and 50 minutes after they’d stopped, becoming slower than those who hadn’t exercised.

It’s not clear why this might be the case, or whether it’s linked with other major depressive disorder symptoms at all.

 

The fact there’s an immediate improvement to mood and general enjoyment after physical activity helps build a case for people with depression that just might encourage them to exercise more.

That said, it might also not be that simple. Depression saps motivation, meaning even anticipation of the buzz that comes with getting out of the house and moving might not be enough to drive a change in habit.

Still, for those who do manage to take the critical step, knowing there’s a window of at least an hour where the dark cloud lifts could help plan out the day a bit better.

“The cool thing is these benefits to depressed mood state and anhedonia could last beyond 75 minutes,” says Meyer.

“We would need to do a longer study to determine when they start to wane, but the results suggest a window of time post-exercise when it may be easier or more effective for someone with depression to do something psychologically or cognitively demanding.”

This research was published in Psychology of Sport and Exercise.

 

Read original article here